Free Trial

Raymond James Financial Inc. Buys New Shares in Delek US Holdings, Inc. (NYSE:DK)

Delek US logo with Energy background
Remove Ads

Raymond James Financial Inc. bought a new position in shares of Delek US Holdings, Inc. (NYSE:DK - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 275,702 shares of the oil and gas company's stock, valued at approximately $5,100,000. Raymond James Financial Inc. owned approximately 0.44% of Delek US at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Orion Portfolio Solutions LLC lifted its position in Delek US by 7.6% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 18,254 shares of the oil and gas company's stock valued at $342,000 after purchasing an additional 1,292 shares during the period. KBC Group NV boosted its stake in Delek US by 66.3% in the fourth quarter. KBC Group NV now owns 3,859 shares of the oil and gas company's stock valued at $71,000 after acquiring an additional 1,538 shares during the last quarter. Van ECK Associates Corp boosted its stake in Delek US by 17.8% in the fourth quarter. Van ECK Associates Corp now owns 14,111 shares of the oil and gas company's stock valued at $261,000 after acquiring an additional 2,134 shares during the last quarter. Rhumbline Advisers grew its holdings in Delek US by 2.0% during the 4th quarter. Rhumbline Advisers now owns 117,170 shares of the oil and gas company's stock worth $2,168,000 after acquiring an additional 2,268 shares during the period. Finally, Wedge Capital Management L L P NC raised its position in shares of Delek US by 8.5% during the 4th quarter. Wedge Capital Management L L P NC now owns 31,856 shares of the oil and gas company's stock valued at $589,000 after acquiring an additional 2,493 shares during the last quarter. 97.01% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

DK has been the subject of a number of analyst reports. Wells Fargo & Company lifted their price objective on Delek US from $15.00 to $16.00 and gave the stock an "underweight" rating in a research note on Friday, March 21st. Mizuho lowered their price target on Delek US from $26.00 to $25.00 and set a "neutral" rating for the company in a research note on Monday, December 16th. Morgan Stanley reduced their price objective on shares of Delek US from $19.00 to $18.00 and set an "underweight" rating on the stock in a research note on Friday, March 14th. Wolfe Research raised shares of Delek US from an "underperform" rating to a "peer perform" rating in a research note on Friday, January 3rd. Finally, JPMorgan Chase & Co. increased their target price on shares of Delek US from $21.00 to $22.00 and gave the stock a "neutral" rating in a report on Tuesday, December 10th. Five equities research analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $20.40.

Get Our Latest Report on DK

Delek US Stock Down 2.6 %

Shares of Delek US stock traded down $0.42 on Friday, hitting $15.66. The company had a trading volume of 570,647 shares, compared to its average volume of 1,180,474. Delek US Holdings, Inc. has a twelve month low of $13.40 and a twelve month high of $33.60. The company has a debt-to-equity ratio of 3.18, a current ratio of 1.04 and a quick ratio of 0.67. The stock has a 50-day moving average of $17.03 and a 200-day moving average of $17.85. The firm has a market capitalization of $978.83 million, a P/E ratio of -3.22 and a beta of 1.14.

Delek US (NYSE:DK - Get Free Report) last announced its earnings results on Tuesday, February 25th. The oil and gas company reported ($2.54) earnings per share for the quarter, missing analysts' consensus estimates of ($1.53) by ($1.01). The company had revenue of $2.37 billion during the quarter, compared to analyst estimates of $2.58 billion. Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. Delek US's revenue for the quarter was down 39.8% on a year-over-year basis. During the same period in the previous year, the company posted ($1.46) earnings per share. Research analysts predict that Delek US Holdings, Inc. will post -5.5 earnings per share for the current year.

Delek US Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 10th. Investors of record on Monday, March 3rd were given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 6.51%. The ex-dividend date of this dividend was Monday, March 3rd. Delek US's dividend payout ratio is presently -11.54%.

Insider Buying and Selling at Delek US

In other Delek US news, CFO Mark Wayne Hobbs purchased 2,800 shares of the stock in a transaction on Tuesday, March 11th. The shares were purchased at an average cost of $13.70 per share, for a total transaction of $38,360.00. Following the purchase, the chief financial officer now owns 49,138 shares of the company's stock, valued at approximately $673,190.60. This represents a 6.04 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last quarter, insiders have bought 5,055 shares of company stock worth $70,787. Corporate insiders own 1.80% of the company's stock.

About Delek US

(Free Report)

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.

Further Reading

Institutional Ownership by Quarter for Delek US (NYSE:DK)

Should You Invest $1,000 in Delek US Right Now?

Before you consider Delek US, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.

While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads